New drug could tackle deadly pregnancy complication
NCT ID NCT07327255
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This early-stage trial tests a new medicine called EG-101 in 24 healthy women to make sure it is safe before trying it in pregnant women with severe pre-eclampsia, a dangerous condition that causes high blood pressure and can harm both mother and baby. The study gives a single dose and monitors how the body processes the drug and any side effects. It is a first step toward a possible treatment to control this life-threatening disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.